ENVB Annual Total Long Term Liabilities
$0.00
$0.000.00%
31 December 2023
Summary:
As of January 23, 2025, ENVB annual total long term liabilities is $0.00, unchanged on December 31, 2023. During the last 3 years, it has risen by $0.00 (0.00%). ENVB annual total long term liabilities is now -100.00% below its all-time high of $15.14 million, reached on December 31, 2016.ENVB Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENVB Quarterly Long Term Liabilities
$0.00
$0.000.00%
30 September 2024
Summary:
As of January 23, 2025, ENVB quarterly total long term liabilities is $0.00, unchanged on September 30, 2024. Over the past year, it has stayed the same.ENVB quarterly long term liabilities is now -100.00% below its all-time high of $19.75 million, reached on September 30, 2016.ENVB Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENVB Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | 0.0% | 0.0% |
| 3 y3 years | 0.0% | 0.0% |
| 5 y5 years | -100.0% | 0.0% |
ENVB Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | -100.0% | ||
| 5 y | 5-year | -100.0% | -100.0% | ||
| alltime | all time | -100.0% | -100.0% |
Enveric Biosciences Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $0.00(0.0%) |
| June 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(0.0%) |
| June 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2022 | - | $4.66 M(+27.8%) |
| June 2022 | - | $3.64 M(-35.4%) |
| Mar 2022 | - | $5.64 M(+236.7%) |
| Dec 2021 | $1.68 M(>+9900.0%) | $1.68 M(-86.3%) |
| Sept 2021 | - | $12.23 M(+229.7%) |
| June 2021 | - | $3.71 M(-39.9%) |
| Mar 2021 | - | $6.17 M(>+9900.0%) |
| Dec 2020 | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2020 | - | $825.20 K(-55.6%) |
| June 2020 | - | $1.86 M(>+9900.0%) |
| Mar 2020 | - | $0.00(0.0%) |
| Dec 2019 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2019 | - | $0.00(-100.0%) |
| June 2019 | - | $4.25 M(-8.4%) |
| Mar 2019 | - | $4.64 M(+10.7%) |
| Dec 2018 | $4.19 M(+76.0%) | $4.19 M(+42.4%) |
| Sept 2018 | - | $2.94 M(+35.1%) |
| June 2018 | - | $2.18 M(-4.5%) |
| Mar 2018 | - | $2.28 M(-4.3%) |
| Dec 2017 | $2.38 M(-84.3%) | $2.38 M(-30.5%) |
| Sept 2017 | - | $3.43 M(-81.1%) |
| June 2017 | - | $18.08 M(+2.5%) |
| Mar 2017 | - | $17.64 M(+16.6%) |
| Dec 2016 | $15.14 M(+202.7%) | $15.14 M(-23.4%) |
| Sept 2016 | - | $19.75 M(+259.2%) |
| June 2016 | - | $5.50 M(0.0%) |
| Mar 2016 | - | $5.50 M(+1.9%) |
| Dec 2015 | $5.00 M(>+9900.0%) | - |
| Sept 2015 | - | $5.40 M(+8.0%) |
| June 2015 | - | $5.00 M(>+9900.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00 | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | - | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2009 | - | $0.00(0.0%) |
| June 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2005 | - | $1200.00(0.0%) |
| June 2005 | - | $1200.00(0.0%) |
| Mar 2005 | - | $1200.00(0.0%) |
| Dec 2004 | $1200.00(-98.3%) | $1200.00(-96.2%) |
| Sept 2004 | - | $31.90 K(-29.9%) |
| June 2004 | - | $45.50 K(-22.6%) |
| Mar 2004 | - | $58.80 K(-18.2%) |
| Dec 2003 | $71.90 K(+7090.0%) | $71.90 K(+3.6%) |
| Sept 2003 | - | $69.40 K(+6840.0%) |
| June 2003 | - | $1000.00(0.0%) |
| Mar 2003 | - | $1000.00(0.0%) |
| Dec 2002 | $1000.00(>+9900.0%) | $1000.00(>+9900.0%) |
| Dec 1999 | $0.00(0.0%) | - |
| Dec 1998 | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 1997 | $33.40 K(>+9900.0%) | $33.40 K(>+9900.0%) |
| Dec 1996 | $0.00 | $0.00 |
FAQ
- What is Enveric Biosciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for Enveric Biosciences?
- What is Enveric Biosciences annual total long term liabilities year-on-year change?
- What is Enveric Biosciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Enveric Biosciences?
- What is Enveric Biosciences quarterly long term liabilities year-on-year change?
What is Enveric Biosciences annual total long term liabilities?
The current annual total long term liabilities of ENVB is $0.00
What is the all time high annual total long term liabilities for Enveric Biosciences?
Enveric Biosciences all-time high annual total long term liabilities is $15.14 M
What is Enveric Biosciences annual total long term liabilities year-on-year change?
Over the past year, ENVB annual total long term liabilities has changed by $0.00 (0.00%)
What is Enveric Biosciences quarterly total long term liabilities?
The current quarterly long term liabilities of ENVB is $0.00
What is the all time high quarterly long term liabilities for Enveric Biosciences?
Enveric Biosciences all-time high quarterly total long term liabilities is $19.75 M
What is Enveric Biosciences quarterly long term liabilities year-on-year change?
Over the past year, ENVB quarterly total long term liabilities has changed by $0.00 (0.00%)